Literature DB >> 21658615

Transformation of follicular lymphoma.

Izidore S Lossos1, Randy D Gascoyne.   

Abstract

Histological transformation of follicular lymphoma (FL) to a more aggressive non-Hodgkin's lymphomas is a pivotal event in the natural history of FL and is associated with poor outcome. While commonly observed in clinical practice and despite multiple studies designed to address its pathogenesis, the biology of this process represents an enigma. In this chapter we present a state of the art review summarizing the definition of histologic transformation, its incidence, pathogenesis, clinical manifestations, treatment and outcome. Furthermore, we specifically emphasize gaps in our knowledge that should be addressed in future studies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21658615      PMCID: PMC3112479          DOI: 10.1016/j.beha.2011.02.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  119 in total

1.  Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.

Authors:  M B Møller; O Nielsen; N T Pedersen
Journal:  Histopathology       Date:  2002-10       Impact factor: 5.087

Review 2.  Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors.

Authors:  Daphne de Jong
Journal:  J Clin Oncol       Date:  2005-09-10       Impact factor: 44.544

3.  Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.

Authors:  Ying Guo; Kennosuke Karube; Riko Kawano; Junji Suzumiya; Morishige Takeshita; Masahiro Kikuchi; Gao-Sheng Huang; Qing Li; Koichi Ohshima
Journal:  Pathol Int       Date:  2007-03       Impact factor: 2.534

4.  Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma.

Authors:  D De Jong; B M Voetdijk; G C Beverstock; G J van Ommen; R Willemze; P M Kluin
Journal:  N Engl J Med       Date:  1988-05-26       Impact factor: 91.245

5.  Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

Authors:  Thomas E Witzig; Leo I Gordon; Fernando Cabanillas; Myron S Czuczman; Christos Emmanouilides; Robin Joyce; Brad L Pohlman; Nancy L Bartlett; Gregory A Wiseman; Norman Padre; Antonio J Grillo-López; Pratik Multani; Christine A White
Journal:  J Clin Oncol       Date:  2002-05-15       Impact factor: 44.544

6.  Frequency of BCL2 and BCL6 translocations in follicular lymphoma: relation with histological and clinical features.

Authors:  Andrea Díaz-Alderete; Angela Doval; Francisca Camacho; Lydia Verde; Pilar Sabin; Reyes Arranz-Sáez; Carmen Bellas; Carlos Corbacho; Juana Gil; María Perez-Martín; Maria Ruiz-Marcellán; Leocricia Gonzalez; Carlos Montalbán; Miguel Piris; Javier Menarguez
Journal:  Leuk Lymphoma       Date:  2008-01

7.  A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients.

Authors:  Andrew J Gentles; Ash A Alizadeh; Su-In Lee; June H Myklebust; Catherine M Shachaf; Babak Shahbaba; Ronald Levy; Daphne Koller; Sylvia K Plevritis
Journal:  Blood       Date:  2009-07-27       Impact factor: 22.113

8.  Histological transformation of non-Hodgkin's lymphoma: a prospective study.

Authors:  M H Cullen; T A Lister; R I Brearley; W S Shand; A G Stansfeld
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

9.  Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.

Authors:  Abdulwahab J Al-Tourah; Karamjit K Gill; Mukesh Chhanabhai; Paul J Hoskins; Richard J Klasa; Kerry J Savage; Laurie H Sehn; Tamara N Shenkier; Randy D Gascoyne; Joseph M Connors
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

10.  Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma).

Authors:  A Matolcsy; G Inghirami; D M Knowles
Journal:  Blood       Date:  1994-03-01       Impact factor: 22.113

View more
  43 in total

1.  Genetics of follicular lymphoma transformation.

Authors:  Laura Pasqualucci; Hossein Khiabanian; Marco Fangazio; Mansi Vasishtha; Monica Messina; Antony B Holmes; Peter Ouillette; Vladimir Trifonov; Davide Rossi; Fabrizio Tabbò; Maurilio Ponzoni; Amy Chadburn; Vundavalli V Murty; Govind Bhagat; Gianluca Gaidano; Giorgio Inghirami; Sami N Malek; Raul Rabadan; Riccardo Dalla-Favera
Journal:  Cell Rep       Date:  2014-01-02       Impact factor: 9.423

2.  Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma.

Authors:  Jason P Wong; Timothy J Stuhlmiller; Louise C Giffin; Carolina Lin; Rachele Bigi; Jichen Zhao; Weihe Zhang; Ariana G Bravo Cruz; Steven I Park; H Shelton Earp; Dirk P Dittmer; Stephen V Frye; Xiaodong Wang; Gary L Johnson; Blossom Damania
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

Review 3.  Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?

Authors:  Sarah Barton; Eliza A Hawkes; Andrew Wotherspoon; David Cunningham
Journal:  Oncologist       Date:  2012-10-18

4.  What's New in Histological Transformation of Indolent Lymphomas?

Authors:  Anca Ciobanu; Anca Lupu
Journal:  Maedica (Buchar)       Date:  2011-10

Review 5.  The heterogeneity of follicular lymphomas: from early development to transformation.

Authors:  Luc Xerri; Stephan Dirnhofer; Leticia Quintanilla-Martinez; Birgitta Sander; John K C Chan; Elias Campo; Steven H Swerdlow; German Ott
Journal:  Virchows Arch       Date:  2015-10-19       Impact factor: 4.064

6.  Transformation of follicular lymphoma in the retroperitoneal muscles demonstrated by CT-guided needle biopsy of FDG-avid lesions; case series.

Authors:  Masahiro Uni; Fumihiko Nakamura; Akihide Yoshimi; Aya Shinozaki-Ushiku; Atsuko Hosoi; Kumi Nakazaki; Yasuhito Nannya; Masashi Fukayama; Mineo Kurokawa
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 7.  Pathogenesis of follicular lymphoma.

Authors:  Robert Kridel; Laurie H Sehn; Randy D Gascoyne
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

8.  Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response.

Authors:  Wendy Béguelin; Matt Teater; Cem Meydan; Kenneth B Hoehn; Jude M Phillip; Alexey A Soshnev; Leandro Venturutti; Martín A Rivas; María T Calvo-Fernández; Johana Gutierrez; Jeannie M Camarillo; Katsuyoshi Takata; Karin Tarte; Neil L Kelleher; Christian Steidl; Christopher E Mason; Olivier Elemento; C David Allis; Steven H Kleinstein; Ari M Melnick
Journal:  Cancer Cell       Date:  2020-05-11       Impact factor: 31.743

9.  The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.

Authors:  Luca Arcaini; Davide Rossi; Marco Lucioni; Marta Nicola; Alessio Bruscaggin; Valeria Fiaccadori; Roberta Riboni; Antonio Ramponi; Virginia V Ferretti; Stefania Cresta; Gloria Margiotta Casaluci; Maurizio Bonfichi; Manuel Gotti; Michele Merli; Aldo Maffi; Mariarosa Arra; Marzia Varettoni; Sara Rattotti; Lucia Morello; Maria Luisa Guerrera; Roberta Sciarra; Gianluca Gaidano; Mario Cazzola; Marco Paulli
Journal:  Haematologica       Date:  2014-11-07       Impact factor: 9.941

10.  Cell of origin of transformed follicular lymphoma.

Authors:  Robert Kridel; Anja Mottok; Pedro Farinha; Susana Ben-Neriah; Daisuke Ennishi; Yvonne Zheng; Elizabeth A Chavez; Hennady P Shulha; King Tan; Fong Chun Chan; Merrill Boyle; Barbara Meissner; Adele Telenius; Laurie H Sehn; Marco A Marra; Sohrab P Shah; Christian Steidl; Joseph M Connors; David W Scott; Randy D Gascoyne
Journal:  Blood       Date:  2015-08-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.